HomeCompareMEDOF vs SPHD

MEDOF vs SPHD: Dividend Comparison 2026

MEDOF yields 4.00% · SPHD yields 4.30%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPHD wins by $545.00 in total portfolio value
10 years
MEDOF
MEDOF
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.9K
Annual income
$517.11
Full MEDOF calculator →
SPHD
SPHD
● Live price
4.30%
Share price
$49.61
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$567.37
Full SPHD calculator →

Portfolio growth — MEDOF vs SPHD

📍 SPHD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEDOFSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEDOF + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MEDOF pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDOF
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$439.54/yr
SPHD
Annual income on $10K today (after 15% tax)
$365.92/yr
After 10yr DRIP, annual income (after tax)
$482.26/yr
At 15% tax rate, SPHD beats the other by $42.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDOF + SPHD for your $10,000?

MEDOF: 50%SPHD: 50%
100% SPHD50/50100% MEDOF
Portfolio after 10yr
$26.2K
Annual income
$542.24/yr
Blended yield
2.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MEDOF right now

MEDOF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
4.2
Piotroski
5/9
SPHD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDOF buys
0
SPHD buys
0
No recent congressional trades found for MEDOF or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEDOFSPHD
Forward yield4.00%4.30%
Annual dividend / share$2.00$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$25.9K$26.5K
Annual income after 10y$517.11$567.37
Total dividends collected$4.6K$5.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MEDOF vs SPHD ($10,000, DRIP)

YearMEDOF PortfolioMEDOF Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$11,100$400.00$11,130$430.50$30.00SPHD
2$12,292$414.95$12,357$447.82$65.00SPHD
3$13,582$429.45$13,687$464.65$105.00SPHD
4$14,976$443.47$15,126$480.98$150.00SPHD
5$16,481$457.01$16,682$496.78$201.00SPHD
6$18,105$470.04$18,362$512.03$257.00SPHD
7$19,855$482.57$20,174$526.72$319.00SPHD
8$21,739$494.59$22,127$540.84$388.00SPHD
9$23,767$506.10$24,230$554.39$463.00SPHD
10$25,948$517.11$26,493$567.37$545.00SPHD

MEDOF vs SPHD: Complete Analysis 2026

MEDOFStock

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Full MEDOF Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this MEDOF vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDOF vs SCHDMEDOF vs JEPIMEDOF vs OMEDOF vs KOMEDOF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.